Genopathy
Gene-Disorder Association · Article
Gene
CYP2D6
Cytochrome P450 Family 2 Subfamily D Member 6 (Gene/Pseudogene)
Disorder
Drug Metabolism, Altered, Cyp2d6-Related
First reported 1977
Key publication · disorder Polymorphic hydroxylation of Debrisoquine in man.Lancet (London, England) · 1977
Manually curated
Association Review

In brief

The association between CYP2D6 (Cytochrome P450 Family 2 Subfamily D Member 6 (Gene/Pseudogene)) and Drug Metabolism, Altered, Cyp2d6-Related is a manually-curated gene–disease association, drawing on a single expert-curated source, which records a known molecular basis and a susceptibility locus.

Sources 1
Clinical variants 0
Symptoms 10
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CYP2D6

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Drug Metabolism, Altered, Cyp2d6-Related

The disorder

4 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

2 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Mechanism overlap

Shared mechanisms

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
07
Provenance

References & sources

3 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access